Results 281 to 290 of about 1,662,629 (361)

Editorial: The role of gut microbiota-gut-brain axis in inflammatory bowel disease. [PDF]

Front Med (Lausanne)
Yao J.
europepmc   +1 more source

Clinical trials of topical agents: Easy application but difficult design

Perspectives in Clinical Research
openaire   +2 more sources

Editorial: International perspectives on older adult social isolation and loneliness. [PDF]

Front Public Health
Kaye LW, Lubben J, Bern-Klug M, Ng TKS, O'Sullivan R, Smith ML.   +5 more
europepmc   +1 more source

Surgical management of injuries to the abdomen in patients with multiple and/or severe trauma- a systematic review and clinical practice guideline update. [PDF]

Eur J Trauma Emerg Surg
Güsgen C, Breuing J, Prediger B, Bieler D, Schwab R.   +4 more
europepmc   +1 more source

Editorial: New horizons in stroke management. [PDF]

Front Hum Neurosci
Kashou N.
europepmc   +1 more source

Understanding Barriers and Facilitators for Ethnic Minority Groups to Audio Recording Recruitment Discussions in Clinical Trials: A Participatory Approach to Improving Informed Consent and Participation. [PDF]

Health Expect
Faisal S, Birchley G, Wade J, Lane A, Malik F, Yardley T, Dawson S.   +6 more
europepmc   +1 more source

Timely Topics in Statistical Methods for Clinical Trials

Annual Review of Biophysics and Bioengineering, 1982
Clinical trials provide information on the absolute and relative efficacy and side effects of medical treatments. These studies range from the well-designed, randomized controlled trial to a study of a single treat­ ment on a series of patients compared to the responses of previous patients treated another way.
Frederick Mosteller, Thomas A. Louis, Bucknam McPeek   +2 more
openaire   +4 more sources

Some topics of current interest in clinical trials

Canadian Journal of Statistics, 1992
AbstractAfter a short review of the development of the modern approach to the design of clinical trials, attention is focused on the wide variety of trials, their ethical constraints, the criteria for stopping trials, and the possible use of Bayesian methods. Brief discussions are then presented of two specific topics: the analysis of categorical data,
P. Armitage
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Perspectives on Virtual (Remote) Clinical Trials as the “New Normal” to Accelerate Drug Development

Clinical pharmacology and therapy, 2021
Although the digital revolution has transformed many areas of human endeavor, pharmaceutical drug development has been relatively slow to embrace the emerging technologies to enhance efficiency and optimize value in clinical trials.
D. Alemayehu, R. Hemmings, Kannan Natarajan, Satrajit Roychoudhury   +3 more
semanticscholar   +1 more source